论文部分内容阅读
慢性粒细胞性白血病临床上虽较急性白血病少见,但仍是一种严重危害人类健康的疾病。由于多侵犯青壮年,而且目前尚缺少根治的办法。据国内外资料的统计,认为一旦症状出现,患者的平均寿命仅3～4年,偶有长达10余年者。如积极进行治疗,仍能有效控制症状,甚至使病人恢复劳动力。近年来有关慢性白血病的文献报告不多,在治疗上的进展远不如急性白血病显著。为探索新的治疗方法,中国医学科学院分院附属医院试用当归芦荟丸治疗本病获得可喜的疗效。我院地处农村,面对贫下中农,为提高疗效、缩短疗程以减轻贫下中农患者的负担而采用二溴甘露醇与马利兰联合应用,并配合中草药治疗慢性粒细胞性白血病2例,与单用马利兰治疗的患者作比较、获得较满意的疗效,现简单报告如下:
Chronic myelogenous leukemia is clinically more acute than acute leukemia, but it is still a serious disease that endangers human health. Due to many violations of young adults, there is still a lack of cure. According to statistics at home and abroad, that once the symptoms appear, the average life expectancy of patients is only 3 to 4 years, occasionally up to 10 years. Active treatment can still effectively control the symptoms and even restore the patient’s workforce. In recent years, few reports on chronic leukemia literature, the progress of treatment is far less than acute leukemia significantly. In order to explore new treatment methods, the Chinese Academy of Medical Sciences Affiliated Hospital trial Angelica aloe pill to treat the disease to obtain gratifying effect. Our hospital is located in rural areas, the face of poor and middle peasants, in order to improve efficacy and shorten the course of treatment to reduce the burden on poor middle-class patients with dibromo-mannitol combined with Maryland, and with Chinese herbal medicine in the treatment of chronic myelogenous leukemia in 2 cases, Marilyn treated patients for more satisfactory results, are now simply reported as follows: